IBRX – immunitybio, inc. (US:NASDAQ)
Stock Stats
News
ImmunityBio Announces NCCN® Clinical Practice Guidelines in Oncology Have Been Updated to Include ANKTIVA® Plus BCG for Patients With BCG-Unresponsive NMIBC With Papillary-Only Disease
IBRX Stock Jumps on Progress in NK Cell Therapy Production [Yahoo! Finance]
Is ImmunityBio, Inc. (IBRX) A Good Stock To Buy Now? [Yahoo! Finance]
ImmunityBio (IBRX) was upgraded by BTIG Research to "strong-buy".
ImmunityBio (IBRX) Climbs 7.3% as Firm Nears Development of ‘World Bank of NK Cells' [Yahoo! Finance]
Form 4 ImmunityBio, Inc. For: Feb 24 Filed by: Simon Barry J.
Form SCHEDULE 13D/A ImmunityBio, Inc. Filed by: Cambridge Equities, LP
Form 4 ImmunityBio, Inc. For: Feb 23 Filed by: Selecky Christobel
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: Adcock Richard
Form 4 ImmunityBio, Inc. For: Feb 22 Filed by: LAUER REGAN J
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.